Zhong Guo Jing Ji Wang·2025-11-22 08:04Core Viewpoint - 聚石化学 is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact its stock performance and investor confidence [1] Group 1: Company Financials - 聚石化学's revenue for 2023, 2024, and the first half of 2025 was reported as 3.685 billion yuan, 4.080 billion yuan, and 1.977 billion yuan respectively [3] - The net profit attributable to shareholders for the same periods was 29 million yuan, -236 million yuan, and 3 million yuan, indicating a significant decline in profitability [3] - The net profit excluding non-recurring gains and losses was -25 million yuan, -206 million yuan, and -16 million yuan for 2023, 2024, and the first half of 2025 respectively, showing continuous losses [3] Group 2: Stock Performance and Issuance - 聚石化学 was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on January 25, 2021, with an initial issuance of 23.33 million shares at a price of 36.65 yuan per share [1] - The stock reached a peak price of 59.50 yuan on its first trading day but has since entered a state of decline, currently trading below its initial offering price [1] - The company plans to raise up to 400 million yuan through a private placement of A-shares, with the funds intended for working capital [2] Group 3: Regulatory Actions - 聚石化学 received a notice from the CSRC regarding the investigation into its information disclosure practices, which is based on the Securities Law and the Administrative Penalty Law of the People's Republic of China [1] - The company previously faced scrutiny from the Shanghai Stock Exchange for correcting its earnings forecast, which led to regulatory inquiries [4] - The financial officer of 聚石化学 has been held accountable for the discrepancies in the earnings forecast, and the company has committed to improving its internal controls to prevent future issues [4]